West Family Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,876
Closed -$465K 269
2025
Q4
$465K Sell
4,876
-1,441
-23% -$141K 0.11% 183
2025
Q3
$617K Buy
6,317
+32
+0.5% +$3.31K 0.14% 137
2025
Q2
$675K Buy
6,285
+3,897
+163% +$394K 0.18% 119
2025
Q1
$241K Sell
2,388
-2,692
-53% -$271K 0.09% 208
2024
Q4
$454K Buy
5,080
+82
+2% +$7.22K 0.16% 131
2024
Q3
$419K Buy
4,998
+490
+11% +$38.6K 0.14% 149
2024
Q2
$347K Buy
4,508
+122
+3% +$8.93K 0.1% 154
2024
Q1
$300K Buy
4,386
+32
+0.7% +$2.06K 0.09% 179
2023
Q4
$252K Buy
4,354
+473
+12% +$25.2K 0.09% 183
2023
Q3
$205K Hold
3,881
0.07% 211
2023
Q2
$210K Buy
+3,881
New +$203K 0.08% 210

Other funds holding BSX

West Family Investments's BSX Position: Q1 2026 in Review

West Family Investments sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 4,876 shares — an estimated $465K sold.

West Family Investments first reported a position in BSX in Q2 2023 and held it in 11 quarters. The position peaked at $675K in Q2 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • West Family Investments reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • West Family Investments sold 4,876 Boston Scientific shares in Q1 2026, an estimated $465K.
  • West Family Investments first reported a position in Boston Scientific in Q2 2023 and held it in 11 quarters.
  • West Family Investments's Boston Scientific position peaked at $675K in Q2 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on West Family Investments's 13F filing for Q1 2026, filed 7 May 2026.